<DOC>
	<DOCNO>NCT00417794</DOCNO>
	<brief_summary>The purpose study determine atomoxetine hydrochloride improve inattention , hyperactivity , impulsivity problem child expose alcohol birth .</brief_summary>
	<brief_title>Assess Effectiveness Atomoxetine Children With Fetal Alcohol Syndrome ADD/ADHD</brief_title>
	<detailed_description>Abnormalities attention , function , activity level child expose alcohol utero share similarity differences child alcohol exposure . Previous psychological study examine either core attention deficit hyperactivity disorder ( ADHD ) symptoms hyperactivity , inattention , impulsivity hypothesize neuropsychological difference child fetal alcohol syndrome ( FAS ) ADHD . Atomoxetine Hydrochloride non-stimulant medication use treat ADHD . This study determine atomoxetine HCL significantly reduce symptom ADD/ADHD child fetal alcohol exposure .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Fetal Alcohol Spectrum Disorders</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Patient must age 4 11 year time entry study . Patients must meet diagnostic criterion FASD Patient must meet DSMIV criterion ADHD , subtype must ADHDRSIV score &gt; = 90 % ile age gender either subtest total score great 5 year age . Patients enter study visit 1 take stimulant medication must medicationfree least 24 hour visit 2 . History physical exam must reveal clinically significant abnormality would preclude safe participation study . Patients must able swallow capsule . Patients must sufficient developmental level ( ~3 yrs ) participate study . Patients parent must able communicate effectively investigator coordinator judge reliable keep appointment participate data collection . Teacher must agree cooperate study . Children le 6 year old must complete course PCIT still meet DSMIV criterion ADHD . Have receive investigational medication past 30 day . Are currently medication treatment effective ( ADHDRSIV score within 1 SD average ) well tolerate . Have significant current medical condition could exacerbate compromised atomoxetine . Have use MAOIs within one month prior visit 2 . Patients hypertension . Patients previous diagnosis bipolar disorder , psychosis , autism spectrum disorder . Patients take anticonvulsant seizure control . Patients take another psychotropic medication health food supplement purport central nervous system activity within 5 halflives visit 2 . Patients Tourette Disorder neurological condition would interfere ability receive treatment comply monitoring . Pubertal girl .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>attention deficit hyperactivity disorder</keyword>
	<keyword>ADHD</keyword>
	<keyword>fetal alcohol syndrome</keyword>
	<keyword>FAS</keyword>
	<keyword>FASD</keyword>
	<keyword>atomoxetine hcl</keyword>
</DOC>